Synthesis and PGE2 production inhibition of s-triazine derivatives as a novel scaffold in RAW 264.7 macrophage cells
摘要:
We present the synthesis and biological evaluation of a collection of s-triazine derivatives as a novel scaffold of compounds with the capability to inhibit the PGE(2) production in LPS-induced RAW 264.7 macrophage cells. A total of 12 derivatives were synthesized and assayed for PGE(2) reduction at 10 mu M concentration. Two compounds (7b and 7i) exhibiting >90% inhibition of PGE(2) production were found to have IC50 values of 5.76 and 5.52 mu M, respectively. They were counter screened for inhibition on COX-2 activity in a cell free assay. Specifically, compound 7i (R-1 = 4-Bn-Ph, R-2 = Cl, R-3 = Ph, R-5 = CO2Me) was highly active in cells while maintaining little COX-2 inhibition (similar to 0% at 10 mu M). Molecular docking study provides the possibility that compound 7i could inhibit PGE(2) production by blocking the PGH(2) binding site of mPGES-1 instead of COX-2 enzyme. Based on this result, our synthetic efforts will focus on intensive structure-activity relationship (SAR) study of s-triazine scaffold to discovery a potential PGE(2) synthesis inhibitor. (C) 2014 Elsevier Ltd. All rights reserved.
Synthesis and PGE2 production inhibition of s-triazine derivatives as a novel scaffold in RAW 264.7 macrophage cells
摘要:
We present the synthesis and biological evaluation of a collection of s-triazine derivatives as a novel scaffold of compounds with the capability to inhibit the PGE(2) production in LPS-induced RAW 264.7 macrophage cells. A total of 12 derivatives were synthesized and assayed for PGE(2) reduction at 10 mu M concentration. Two compounds (7b and 7i) exhibiting >90% inhibition of PGE(2) production were found to have IC50 values of 5.76 and 5.52 mu M, respectively. They were counter screened for inhibition on COX-2 activity in a cell free assay. Specifically, compound 7i (R-1 = 4-Bn-Ph, R-2 = Cl, R-3 = Ph, R-5 = CO2Me) was highly active in cells while maintaining little COX-2 inhibition (similar to 0% at 10 mu M). Molecular docking study provides the possibility that compound 7i could inhibit PGE(2) production by blocking the PGH(2) binding site of mPGES-1 instead of COX-2 enzyme. Based on this result, our synthetic efforts will focus on intensive structure-activity relationship (SAR) study of s-triazine scaffold to discovery a potential PGE(2) synthesis inhibitor. (C) 2014 Elsevier Ltd. All rights reserved.
Synthesis and PGE2 production inhibition of s-triazine derivatives as a novel scaffold in RAW 264.7 macrophage cells
作者:Seoung Mook Kang、Jinsung Lee、Jae Ho Jin、Minju Kim、Sunhoe Lee、Hwi Ho Lee、Ji-Sun Shin、Kyung-Tae Lee、Jae Yeol Lee
DOI:10.1016/j.bmcl.2014.10.031
日期:2014.12
We present the synthesis and biological evaluation of a collection of s-triazine derivatives as a novel scaffold of compounds with the capability to inhibit the PGE(2) production in LPS-induced RAW 264.7 macrophage cells. A total of 12 derivatives were synthesized and assayed for PGE(2) reduction at 10 mu M concentration. Two compounds (7b and 7i) exhibiting >90% inhibition of PGE(2) production were found to have IC50 values of 5.76 and 5.52 mu M, respectively. They were counter screened for inhibition on COX-2 activity in a cell free assay. Specifically, compound 7i (R-1 = 4-Bn-Ph, R-2 = Cl, R-3 = Ph, R-5 = CO2Me) was highly active in cells while maintaining little COX-2 inhibition (similar to 0% at 10 mu M). Molecular docking study provides the possibility that compound 7i could inhibit PGE(2) production by blocking the PGH(2) binding site of mPGES-1 instead of COX-2 enzyme. Based on this result, our synthetic efforts will focus on intensive structure-activity relationship (SAR) study of s-triazine scaffold to discovery a potential PGE(2) synthesis inhibitor. (C) 2014 Elsevier Ltd. All rights reserved.